Comparative Study of Intravaginal Metronidazole and Triple-Sulfa Therapy for Bacterial Vaginosis

Infectious Diseases in Obstetrics and Gynecology

Volumn 4, Issue 2, 1996, Pages 66-70

  Sobel, Jack D ^a   Chaim, Walter ^a   Thomason, Jessica ^b   Livengood, Charles ^c   Sweet, Richard ^d   Mcgregor, James A ^e   Eschenbach, David ^f   Hillier, Sharon ^g   Galask, Rudolph ^h   Faro, Sebastian ⁱ   Shangle, Elizabeth ^j   Baker, David ^k  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AURORA SINAI MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁱ UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^j LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^k STONY BROOK UNIVERSITY   (United States)

more..

Author keywords

topical therapy; vaginal infection; Vaginitis

Indexed keywords

METRONIDAZOLE; SULTRIN; TRISULFAPYRIMIDINE; UNCLASSIFIED DRUG;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM STAINING; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; VAGINITIS;

EID: 20644445428     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/S1064744996000154     Document Type: Article

References (24)

1. Pheiffer TA, Forsyth PS, Durfee MA, et al.: Non-specific vaginitis: Role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med 298:1429–1434, 1978.
2. Hillier S, Holmes KK: Bacterial vaginosis. In Holmes KK, Mardh P, Sparling F (eds): Sexually Transmitted Diseases. 2nd ed. New York: McGraw-Hill, pp 547–559, 1989.
3. Bistoletti P, Fredricsson B, Hagstrom B, Nord CE: Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 21:144–149, 1986.
4. Eschenbach DA, Critchlow CW, Watkins H, et al.: A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis Suppl 40:73–80, 1983.
5. Blackwell A1, Fox AR, Phillips I, Barlow D: Anaerobic vaginosis (nonspecific vaginitis): Clinical, microbiological and therapeutic findings. Lancet 2:1379–1382, 1983.
6. Lugo-Miro VI, Green M, Mazur L: Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 268:92–95, 1992.
7. Boeke AJ, Dekker JH, van Eijk JT, et al.: Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: A randomized clinical trial. Genitourin Med 69:388–392, 1993.
8. Livengood CH, McGregor JA, Soper DE, et al.: Bacterial vaginosis: Efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 170:159–164, 1994.
9. Schmitt C, Sobel JD, Meriwether C: Bacterial vaginosis: Treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 79:1020–1023, 1992.
10. McDonald HM, O’Loughlin JA, Vigneswaran R, et al.: Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: A randomized controlled trial. Obstet Gynecol 84:343–348, 1994.
11. Greaves WL, Chungafung J, Morris B, et al.: Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 72:799–802, 1988.
12. Livengood CH III, Thomason JL, Hill GB: Bacterial vaginosis: Diagnostic and pathogenic findings during topical clindamycin therapy. Am J Obstet Gynecol 163: 515–520, 1990.
13. Livengood CH III, Thomason JL, Hill GB: Bacterial vaginosis: Treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 76:118–123, 1990.
14. Hillier SL, Krohn MA, Watts DH, Wölner-Hanssen P, Eschenbach DA: Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 76:407–413, 1990.
15. Biswas MK: Bacterial vaginosis. Clin Obstet Gynecol 36:166–176, 1993.
16. Hillier SL, Lepenski CM, Briselden AM, Eschenbach DA: Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 81: 963–967, 1993.
17. Amsel R, Totten PA, Spiegel CA, Chenk CS, Eschenbach D, Holmes KK: Nonspecific vaginitis. Am J Med 74:14–27, 1983.
18. Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 29:297–301, 1991.
19. Piot P, Van Dyck E, Godts P, Vanderheyden J: A placebo-controlled, double-blind comparison of tinidazole and triple sulfonamide cream for treatment of non-specific vaginitis. Am J Obstet Gynecol 147:85–89, 1983.
20. McCarthy LR, Mickelsen PA, Smith EG: Antibiotic susceptibility of Haemophilus vaginalis (Corynebacterium vaginale) to 21 antibiotics. Antimicrob Agents Chemother 16:186–190, 1979.
21. Bailey RK, Voss JL, Mith RF: Factors affecting isolation and identification of Haemophilus vaginalis (Corynebacterium vaginale). J Clin Microbiol 9:65–68, 1979.
22. Rustia M, Shubik P: Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 48:721–729, 1972.
23. Roe FJC: Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 93:158–164, 1983.
24. Beard CM, Noller KL, O’Fallon WM, et al.: Lack of evidence for cancer due to use of metronidazole. N Engl J Med 301:519–522, 1979.